YY1 and neoplasm: In a study by Kwiatkowska et al. [70], they stained human melanoma sections by immunofluorescence, and these showed activation of the p38MAPK/JNK pathway in tumor-infiltrating lymphocytes, which drives YY1 expression, leading to PD-1 and LAG-3 upregulations.